A novel Mcl1 variant inhibits apoptosis via increased bim sequestration

Oncotarget

Volumn 4, Issue 8, 2013, Pages 1241-1252

  Hagenbuchner, Judith ^a,b   Kiechl Kohlendorfer, Ursula ^a   Obexer, Petra ^a,b   Ausserlechner, Michael J ^a,b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Tyrolean Cancer Research Institute   (Australia)

Author keywords

Apoptosis; BCL2 proteins; Mcl1L; mRNA variant

Indexed keywords

ASPARTIC ACID; BIM PROTEIN; CASPASE 3; CASPASE 8; DEATH RECEPTOR; GLYCINE; PROTEIN MCL 1; RETROVIRUS VECTOR; SERINE; THREONINE;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LEUKEMIA CELL; MOLECULAR CLONING; NEUROBLASTOMA CELL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEADY STATE;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BASE SEQUENCE; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CLONING, MOLECULAR; HUMANS; LEUKEMIA; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; MYELOID CELL LEUKEMIA SEQUENCE 1 PROTEIN; NEUROBLASTOMA; PROTEIN STABILITY; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84884297387     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1147     Document Type: Article

References (46)

1. Kozopas KM, Yang T, Buchan HL, Zhou P, and Craig RW, MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2, Proc.Natl. Acad.Sci.U.S.A 1993 90(8):3516-3520.
2. Day CL, Chen L, Richardson SJ, Harrison PJ, Huang DCS, and Hinds MG, Solution Structure of Prosurvival Mcl-1 and Characterization of Its Binding by Proapoptotic BH3-only Ligands, Journal of Biological Chemistry 2005 280(6):4738-4744.
3. Clohessy JG, Zhuang J, and Brady HJM, Characterisation of Mcl-1 cleavage during apoptosis of haematopoietic cells, British Journal of Haematology 2004 125(5):655-665.
4. Domina AM, Smith JH, and Craig RW, Myeloid Cell Leukemia 1 Is Phosphorylated through Two Distinct Pathways, One Associated with Extracellular Signalregulated Kinase Activation and the Other with G2/M Accumulation or Protein Phosphatase 1/2A Inhibition, Journal of Biological Chemistry 2000 275(28):21688- 21694.
5. Domina AM, Vrana JA, Gregory MA, Hann SR, and Craig RW, MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol, Oncogene 2004 23(31):5301-5315.
6. Zhong Q, Gao W, Du F, and Wang X, Mule/ARFBP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis, Cell 2005 121(7):1085-1095.
7. Huang HM, Huang CJ, and Yen JJ, Mcl-1 is a common target of stem cell factor and interleukin-5 for apoptosis prevention activity via MEK/MAPK and PI-3K/Akt pathways, Blood 2000 96(5):1764-1771.
8. Le Gouill S, Podar K, Amiot M, Hideshima T, Chauhan D, Ishitsuka K, Kumar S, Raje N, Richardson PG, Harousseau JL, and Anderson KC, VEGF induces Mcl-1 up-regulation and protects multiple myeloma cells against apoptosis, Blood 2004 104(9):2886-2892.
9. Wang JM, Chao JR, Chen W, Kuo ML, Yen JJ, and Yang- Yen HF, The antiapoptotic gene mcl-1 is up-regulated by the phosphatidylinositol 3-kinase/Akt signaling pathway through a transcription factor complex containing CREB, Mol.Cell Biol. 1999 19(9):6195-6206.
10. Ding Q, Huo L, Yang JY, Xia W, Wei Y, Liao Y, Chang CJ, Yang Y, Lai CC, Lee DF, Yen CJ, Chen YJR, Hsu JM, Kuo HP, Lin CY, Tsai FJ, Li LY, Tsai CH, and Hung MC, Down-regulation of Myeloid Cell Leukemia-1 through Inhibiting Erk/Pin 1 Pathway by Sorafenib Facilitates Chemosensitization in Breast Cancer, Cancer Research 2008 68(15):6109-6117.
11. Inoshita S, Takeda K, Hatai T, Terada Y, Sano M, Hata J, Umezawa A, and Ichijo H, Phosphorylation and inactivation of myeloid cell leukemia 1 by JNK in response to oxidative stress, J.Biol Chem 2002 277(46):43730-43734.
12. Morel C, Carlson SM, White FM, and Davis RJ, Mcl-1 Integrates the Opposing Actions of Signaling Pathways That Mediate Survival and Apoptosis, Molecular and Cellular Biology 2009 29(14):3845-3852.
13. Maurer U, Charvet C, Wagman AS, Dejardin E, and Green DR, Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1, Mol.Cell 2006 21(6):749-760.
14. Cuconati A, Mukherjee C, Perez D, and White E, DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells, Genes Dev. 2003 17(23):2922-2932.
15. Willis SN, Chen L, Dewson G, Wei A, Naik E, Fletcher JI, Adams JM, and Huang DC, Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins, Genes Dev. 2005 19(11):1294-1305.
16. Clohessy JG, Zhuang J, de Boer J, Gil-Gomez G, and Brady HJ, Mcl-1 interacts with truncated Bid and inhibits its induction of cytochrome c release and its role in receptormediated apoptosis, J.Biol.Chem. 2006 281(9):5750-5759.
17. Czabotar PE, Lee EF, van Delft MF, Day CL, Smith BJ, Huang DCS, Fairlie WD, Hinds MG, and Colman PM, Structural insights into the degradation of Mcl-1 induced by BH3 domains, Proceedings of the National Academy of Sciences 2007 104(15):6217-6222.
18. Gomez-Bougie P, Ménoret E, Juin P, Dousset C, Pellat-Deceunynck C, and Amiot M, Noxa controls Muledependent Mcl-1 ubiquitination through the regulation of the Mcl-1/USP9X interaction, Biochemical and Biophysical Research Communications 2011 413(3):460-464.
19. Gomez-Bougie P, Oliver L, Le Gouill S, Bataille R, and Amiot M, Melphalan-induced apoptosis in multiple myeloma cells is associated with a cleavage of Mcl-1 and Bim and a decrease in the Mcl-1/Bim complex, Oncogene 2005 24(54):8076-8079.
20. Wuilleme-Toumi S, Trichet V, Gomez-Bougie P, Gratas C, Bataille R, and Amiot M, Reciprocal protection of Mcl-1 and Bim from ubiquitin-proteasome degradation, Biochem. Biophys.Res.Commun. 2007 361(4):865-869.
21. Herrant M, Jacquel A, Marchetti S, Belhacene N, Colosetti P, Luciano F, and Auberger P, Cleavage of Mcl-1 by caspases impaired its ability to counteract Bim-induced apoptosis, Oncogene 2004 23(47):7863-7873.
22. Ding Q, He X, Hsu JM, Xia W, Chen CT, Li LY, Lee DF, Liu JC, Zhong Q, Wang X, and Hung MC, Degradation of Mcl-1 by betaTrCP Mediates Glycogen Synthase Kinase 3-Induced Tumor Suppression and Chemosensitization, Molecular and Cellular Biology 2007 27(11):4006-4017.
23. Inuzuka H, Shaik S, Onoyama I, Gao D, Tseng A, Maser RS, Zhai B, Wan L, Gutierrez A, Lau AW, Xiao Y, Christie AL, Aster J, Settleman J, Gygi SP, Kung AL, Look T, Nakayama KI, DePinho RA, and Wei W, SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction, Nature 2011 471(7336):104-109.
24. Schwickart M, Huang X, Lill JR, Liu J, Ferrando R, French DM, Maecker H, O'Rourke K, Bazan F, Eastham-Anderson J, Yue P, Dornan D, Huang DCS, and Dixit VM, Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival, Nature 2010 463(7277):103-107.
25. Han J, Goldstein LA, Gastman BR, and Rabinowich H, Interrelated Roles for Mcl-1 and BIM in Regulation of TRAIL-mediated Mitochondrial Apoptosis, J.Biol Chem 2006 281(15):10153-10163.
26. Weng C, Li Y, Xu D, Shi Y, and Tang H, Specific cleavage of Mcl-1 by caspase-3 in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Jurkat leukemia T cells, J.Biol Chem 2005 280(11):10491-10500.
27. Bae J, Leo CP, Hsu SY, and Hsueh AJW, MCL-1S, a Splicing Variant of the Antiapoptotic BCL-2 Family Member MCL-1, Encodes a Proapoptotic Protein Possessing Only the BH3 Domain, Journal of Biological Chemistry 2000 275(33):25255-25261.
28. Bingle CD, Craig RW, Swales BM, Singleton V, Zhou P, and Whyte MKB, Exon Skipping in Mcl-1 Results in a Bcl-2 Homology Domain 3 Only Gene Product That Promotes Cell Death, Journal of Biological Chemistry 2000 275(29):22136-22146.
29. Boise LH, González-García M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nuñez G, and Thompson CB, bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death, Cell 1993 74(4):597-608.
30. Kim JH, Sim SH, Ha HJ, Ko JJ, Lee K, and Bae J, MCL-1ES, a novel variant of MCL-1, associates with MCL-1L and induces mitochondrial cell death, FEBS Letters 2009 583(17):2758-2764.
31. Fujise K, Zhang D, Liu Jl, and Yeh ETH, Regulation of Apoptosis and Cell Cycle Progression by MCL1, Journal of Biological Chemistry 2000 275(50):39458-39465.
32. Jamil S, Sobouti R, Hojabrpour P, Raj M, Kast J, and Duronio V, A proteolytic fragment of Mcl-1 exhibits nuclear localization and regulates cell growth by interaction with Cdk1, Biochem.J. 2005 387(Pt 3):659-667.
33. Thomas LW, Lam C, and Edwards SW, Mcl-1; the molecular regulation of protein function, FEBS Letters 2010 584(14):2981-2989.
34. Hagenbuchner J, Ausserlechner MJ, Porto V, David R, Meister B, Bodner M, Villunger A, Geiger K, and Obexer P, The anti-apoptotic protein BCL2L1/Bcl-xL is neutralized by pro-apoptotic PMAIP1/Noxa in neuroblastoma, thereby determining bortezomib sensitivity independent of prosurvival MCL1 expression, J.Biol.Chem. 2010 285(10):6904-6912.
35. Warr MR, Acoca S, Liu Z, Germain M, Watson M, Blanchette M, Wing SS, and Shore GC, BH3-ligand regulates access of MCL-1 to its E3 ligase, FEBS Lett. 2005 579(25):5603-5608.
36. Mei Y, Du W, Yang Y, and Wu M, Puma(*)Mcl-1 interaction is not sufficient to prevent rapid degradation of Mcl-1, Oncogene 2005 24(48):7224-7237.
37. Thomas LW, Lam C, Clark RE, White MRH, Spiller DG, Moots RJ, and Edwards SW, Serine 162, an Essential Residue for the Mitochondrial Localization, Stability and Anti-Apoptotic Function of Mcl-1, PLoS One 2012 7(9):e45088-
38. Obexer P, Geiger K, Ambros PF, Meister B, and Ausserlechner MJ, FKHRL1-mediated expression of Noxa and Bim induces apoptosis via the mitochondria in neuroblastoma cells, Cell Death Differ 2007 14(3):534-547.
39. Weng C, Li Y, Xu D, Shi Y, and Tang H, Specific cleavage of Mcl-1 by caspase-3 in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Jurkat leukemia T cells, J.Biol.Chem. 2005 280(11):10491-10500.
40. Geiger K, Hagenbuchner J, Rupp M, Fiegl H, Sergi C, Meister B, Kiechl-Kohlendorfer U, Muller T, Ausserlechner MJ, and Obexer P, FOXO3/FKHRL1 is activated by 5-aza-2-deoxycytidine and induces silenced caspase-8 in neuroblastoma, Mol.Biol.Cell 2012 23(11):2226-2234.
41. Ausserlechner MJ, Salvador C, Deutschmann A, Bodner M, Viola G, Bortolozzi R, Basso G, Hagenbuchner J, and Obexer P, Therapy-resistant acute lymphoblastic leukemia (ALL) cells inactivate FOXO3 to escape apoptosis induction by TRAIL and Noxa, Oncotarget 2013 online publication1-13.
42. Grignani F, Kinsella T, Mencarelli A, Valtieri M, Riganelli D, Grignani F, Lanfrancone L, Peschle C, Nolan GP, and Pelicci PG, High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/ retroviral vector expressing the green fluorescence protein, Cancer Res. 1998 58(1):14-19.
43. Ausserlechner MJ, Obexer P, Deutschmann A, Geiger K, and Kofler R, A retroviral expression system based on tetracycline-regulated tricistronic transactivator/repressor vectors for functional analyses of anti-proliferative and toxic genes, Mol.Cancer Ther. 2006 5(8):1927-1934.
44. Hagenbuchner J, Kuznetsov A, Hermann M, Hausott B, Obexer P, and Ausserlechner MJ, FOXO3-induced reactive oxygen species are regulated by BCL2L11 (Bim) and SESN3, J.Cell Sci. 2012 125(Pt 5):1191-1203.
45. Obexer P, Hagenbuchner J, Rupp M, Salvador C, Holzner M, Deutsch M, Porto V, Kofler R, Unterkircher T, and Ausserlechner MJ, p16INK4A sensitizes human leukemia cells to FAS-and glucocorticoid-induced apoptosis via induction of BBC3/Puma and repression of MCL1 and BCL2, J.Biol.Chem. 2009 284(45):30933-30940.
46. Hagenbuchner J, Kuznetsov AV, Obexer P, and Ausserlechner MJ, BIRC5/Survivin enhances aerobic glycolysis and drug resistance by altered regulation of the mitochondrial fusion/fission machinery, Oncogene 2012, online publication